SIGMA-ALDRICH search Sigma-Aldrich TRAF2 products
includes other brands or spellings
|
| ih | | Sigma TRAF2 antibody was tested in immunohistochemistry by Human Protein Atlas. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology TRAF2 products
includes other brands or spellings
|
| ic, ih, wb | | Santa Cruz rabbit anti-TRAF2 antibody C-20, rabbit anti-N-terminal TRAF2 antibody N-19 and mouse monoclonal anti-C-terminal TRAF2 antibody H-10 were used in cultured human cells and biopsied lymph nodes and were respectively used in western blot, immunohistochemistry, immunocytochemistry and immunohistochemistry, immunocytochemistry and immunohistochemistry, immunocytochemistry to study the intracellular localization of tumor necrosis factor (TNF) receptor associated factor (TRAF) proteins in H-RS cells. |
| ip, wb | | Santa Cruz anti-TRAF2 antibodies (N-19 and C-20) were used in human HEK293, HEK293T, MCF-7 cells and in western blot, immunoprecipitation to study the structural features of cIAP1 which is responsible for its interactions with two known target proteins, TRAF2 and SMAC. |
| ip, wb | | Santa Cruz Biotechnology anti-TRAF2 antibody was used in western blot and immunoprecipitation to study the role of AIP1/DAB2IP in the activation of TRAF2-induced ASK1-JNK. |
| ip | | Santa Cruz Biotechnology TRAF2 antibody was used in immunoprecipitation to study the K13-induced NF-B and JNK activation and re-examine the role of TRAFs in these processes. |
| wb | | Santa Cruz Biotechnology anti-TRAF2 antibody was used in western blot to study JNK activation by H2O2. |
| wb | | Santa Cruz Biotechnology anti-TRAF2 antibody was used in western blot to study NAK recruitment to the TNFR1 complex. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal IgG anti-TRAF2 was used in western blot to study the Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2). |
| wb | | Santa Cruz Biotechnology anti-TRAF2 antibody was used in western blot to study the effects of TL1A-induced NF- B and c-IAP2 on DR3-mediated apoptosis in TF-1 cells. |
| wb | | Santa Cruz Biotechnology polyclonal anti-TRAF2 antibody C-20 was used in western blot to study the function of tumor suppressor CYLD in the regulation of JNK signaling. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-TRAF2 antibody was used in western blot to study the endothelial cell survival and in vitro angiogenesis mediating by CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway. |
| wb | | Santa Cruz Biotechnology anti-TRAF2 polyclonal antibody was used in western blot to detect TRAF2 in 293 cells transfected with expression vectors for various versions of Flag-LMP1. |
| wb | | Santa Cruz anti-TRAF2 antibody was used in human Jurkat cells and in western blot to study the roles for receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. |
MBL INTERNATIONAL search MBL International TRAF2 products
includes other brands or spellings
|
| wb | | Medical and Biological Laboratories rabbit polyclonal TRAF2 antibody was used in western blot to study the interaction of LMP1 protein from the Epstein-Barr virus with TRAF3 in B lymphocytes. |
BD BIOSCIENCES search BD Biosciences TRAF2 products
includes other brands or spellings
|
| wb | | BD Transduction Labs anti-TRAF2 antibody was used in western blot to detect TRAF2 in Parental, FADD-deficient, caspase-8-deficient Jurkat cells, HeLa cells and U937 cells. |
MILLIPORE search Millipore TRAF2 products
includes other brands or spellings
|
| ip | | Upstate Biotechnology antibody to TRAF2 was used in immunoprecipitation to identify ASK1 as a key element for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. |
Articles Reviewed |
| 1. Ryouichi Horie et al. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. 2002 |
| 2. Hideki Nishitoh et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. 2002 |
| 3. Maria Chiara Deregibus et al. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. 2003 |
| 4. Nicholas Harper et al. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. 2003 |
| 5. Leng Wen et al. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. 2003 |
| 6. Han-Ming Shen et al. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. 2004 |
| 7. Haifeng Zhang et al. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. 2004 |
| 8. Jun Kuai et al. NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approach. 2004 |
| 9. William Reiley et al. Negative regulation of JNK signaling by the tumor suppressor CYLD. 2004 |
| 10. Andreas Till et al. The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. 2005 |
| 11. Wei Zhang et al. Protein kinase D specifically mediates apoptosis signal-regulating kinase 1-JNK signaling induced by H2O2 but not tumor necrosis factor. 2005 |
| 12. ShuangDing Wu et al. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. 2005 |
| 13. Temesgen Samuel et al. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. 2006 |
| 14. Noriyuki Uemura et al. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB. 2006 |
| 15. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 16. Hittu Matta et al. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. 2007 |